Oligoclonal CAR-T–Derived CD4+ T-Cell Lymphoproliferative Disorder of the Duodenum Following BCMA-Directed CAR-T Therapy for Multiple Myeloma

Name: Oligoclonal CAR-T–Derived CD4+ T-Cell Lymphoproliferative Disorder of the Duodenum Following BCMA-Directed CAR-T Therapy for Multiple Myeloma
Start: 2026-11-18T12:00
End: 2026-11-18T12:45
Location: Palais des congrès de Montréal

2026 ASCP/CAP-ACP Annual Meeting · 18 November 2026 · 12:00–12:45 · 517ABC - Exhibit Hall

Oligoclonal CAR-T–Derived CD4+ T-Cell Lymphoproliferative Disorder of the Duodenum Following BCMA-Directed CAR-T Therapy for Multiple Myeloma was a session at 2026 ASCP/CAP-ACP Annual Meeting on 18 November 2026 in Montreal, with 1 speaker on record.

Speakers

Chauncey Syposs — Speaker University of Rochester Medical Center